Incannex Healthcare Inc.
Most recent annual filing: 2025-09-15
Pipeline (3 active programs)
psilocybin
PSX-001 Small Molecule Target: serotonin receptor
IHL-675A
Small Molecule Target: CBD, hydroxychloroquine
Biotech Distilled coverage (8)
- 2026-05-15 UPDATE: Incannex (IXHL) - DReAMzz Officially Starts. The Clock on Dead Money Begins. 🔒 Paid
- 2026-04-27 UPDATE: Incannex (IXHL) - The White House Throws Psychedelics a Bone, and IXHL Grabs the Microphone
- 2026-03-28 UPDATE: Incannex (IXHL) - Buying Goodwill and Baffling Buybacks
- 2026-03-21 UPDATE: Incannex (IXHL) - Damage Control, Negative Enterprise Value, and the Reality of Biotech Markets
- 2026-03-14 UPDATE: Incannex (IXHL) - The Goalposts Move, The Dilution Hits, and Phase 3 is Delayed to 2027
- 2026-02-28 UPDATE: Incannex (IXHL) - The Predicted Reverse Split Arrives...
- 2026-02-14 UPDATE: Incannex (IXHL) - Q2 Fiscal 2026 Update
- 2026-01-11 Incannex (IXHL): Scientific Deep Dive for IHL-42X and Pipeline Products
Articles open on Substack. Some deep dives are subscriber-only.